Journal for ImmunoTherapy of Cancer (Nov 2020)
329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)